The importance of PAK4 and PHF8 in cancer progression and as therapeutic targets has been emphasized in various human cancers, and the inhibition of PAK4 and PHF8 is under evaluation in cancer therapy [3,10,18,20]. This evidence concerns the gene PAK4 and cancer.